保存的微RNAs 基因揭示了TDP-43病理和帕金森病中MAPK通路激活
Mingyue Luan1, Wei Wu2, Fuze Zheng1
1Department of Neurology, Peking University First Hospital, Beijing, China.
概括
研究人员发现了一种与帕金森病 (PD) 相关的特定微RNA (miRNA) 动机. 由TDP-43聚合引起的这种动机的下调,激活了MAPK通路,为PD提供了潜在的治疗标.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 帕金森病 (PD) 是一种神经退行性疾病,其特征是多巴胺基神经元损失和α-synuclein聚合.
- 微RNA (miRNA) 失调与PD的发病有关,但潜在的机制尚不清楚.
研究的目的:
- 为了识别与帕金森病 (PD) 病理学有关的特定微RNA (miRNAs).
- 阐明这些miRNAs失调的机制及其在PD中的作用.
主要方法:
- 在使用RT-QuIC的PD患者的唾液样本中分析下调的miRNAs.
- 定量实时PCR (RT-qPCR),miRNA拉下测试,以及西布洛特来研究TDP-43的相互作用.
- 对miRNA目标和通路分析的生物信息分析.
- 使用Drosophila PD模型来评估MAPK路径调节的影响.
主要成果:
- 在PD患者中82.5%的下调小RNA中发现了一种保存的5核酸基因 (HBCCC).
- 研究人员发现,TAR DNA 结合蛋白-43 (TDP-43) 能够结合这种基因,调节miRNA生物发生.
- 观察到TDP-43与α-synuclein (α-syn) 的联合聚合,可能导致miRNA下调.
- 含有动机的miRNAs的下调导致了线粒体激活蛋白激酶 (MAPK) 途径的激活.
- 对MAPK通路表达的干扰在Drosophila PD模型中改善了运动障碍.
结论:
- 在帕金森病 (PD) 中提出了一种涉及TDP-43,α-syn和miRNA失调的新机制.
- 已识别的miRNA动机和MAPK通路代表了PD的潜在治疗点.
- 这项研究强调了miRNAs在神经退行性疾病的病理过程中的关键作用.
相关概念视频
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
Microtubule Associated Proteins (MAPs)
5.7K
Microtubule function and architecture are regulated by an array of specialized proteins called microtubule-associated proteins or MAPs. These proteins are widespread across different organisms and have conserved protein motifs, like the multi-TOG domain for tubulin binding found in the CLASP family of MAPs. Some MAPs are lineage-specific based on their conserved domains. Their functions depend upon the cytoskeletal architecture and cell type they are located within. In-plant cells, a specific...
5.7K
Parkinson's Disease: Overview
1.7K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.7K
Abnormal Proliferation
5.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K


